Xiaoling Xuei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiaoling Xuei has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Howard J. Edenberg
Indiana University School of Medicine, Biochemistry and Molecular Biology, Indianapolis, USA
6 shared publications - John I. Nurnberger
Indiana University School of Medicine
4 shared publications - Jay A. Tischfield
Department of Genetics and the Human Genetics Institute of New Jersey, Rutgers, the State University of New Jersey, Piscataway, NJ, 08854, USA
3 shared publications Leah Flury‐Wetherill
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana
3 shared publicationsTatiana Foroud
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana
3 shared publications- Alison M. Goate
Icahn School of Medicine at Mount Sinai
2 shared publications
Latest Publications
- Open Access
- 22 August 2016
- Published by Springer Nature in BMC Genomics
- Vol. 17 (S7) , 514
Statistical modeling for sensitive detection of low-frequency single nucleotide variants
Sensitive detection of low-frequency single nucleotide variants carries great significance in many applications. In cancer genetics research, tumor biopsies are a mixture of normal and tumor cells from various subpopulations due to tumor heterogeneity. Thus the frequencies of somatic variants from a subpopulation tend to be low. Liquid biopsies, which monitor circulating tumor DNA in blood to detect metastatic potential, also face the challenge of detecting low-frequency variants due to the small percentage of the circulating tumor DNA in blood. Moreover, in population genetics research, although pooled sequencing of a large number of individuals is cost-effective, pooling dilutes the signals of variants from any individual. Detection of low frequency variants is difficult and can be cofounded by sequencing artifacts. Existing methods are limited in sensitivity and mainly focus on frequencies around 2 % to 5 %; most fail to consider differential sequencing artifacts. We aimed to push down the frequency detection limit close to the position specific sequencing error rates by modeling the observed erroneous read counts with respect to genomic sequence contexts. 4 distributions suitable for count data modeling (using generalized linear models) were extensively characterized in terms of their goodness-of-fit as well as the performances on real sequencing data benchmarks, which were specifically designed for testing detection of low-frequency variants; two sequencing technologies with significantly different chemistry mechanisms were used to explore systematic errors. We found the zero-inflated negative binomial distribution generalized linear mode is superior to the other models tested, and the advantage is most evident at 0.5 % to 1 % range. This method is also generalizable to different sequencing technologies. Under standard sequencing protocols and depth given in the testing benchmarks, 95.3 % recall and 79.9 % precision for Ion Proton data, 95.6 % recall and 97.0 % precision for Illumina MiSeq data were achieved for SNVs with frequency > = 1 %, while the detection limit is around 0.5 %. Our method enables sensitive detection of low-frequency single nucleotide variants across different sequencing platforms and will facilitate research and clinical applications such as pooled sequencing, cancer early detection, prognostic assessment, metastatic monitoring, and relapses or acquired resistance identification.
- 22 August 2016
- Published by Springer Nature in BMC Genomics
- Vol. 17 (S7) , 514
Open AccessStatistical modeling for sensitive detection of low-frequency single nucleotide variants
Sensitive detection of low-frequency single nucleotide variants carries great significance in many applications. In cancer genetics research, tumor biopsies are a mixture of normal and tumor cells from various subpopulations due to tumor heterogeneity. Thus the frequencies of somatic variants from a subpopulation tend to be low. Liquid biopsies, which monitor circulating tumor DNA in blood to detect metastatic potential, also face the challenge of detecting low-frequency variants due to the small percentage of the circulating tumor DNA in blood. Moreover, in population genetics research, although pooled sequencing of a large number of individuals is cost-effective, pooling dilutes the signals of variants from any individual. Detection of low frequency variants is difficult and can be cofounded by sequencing artifacts. Existing methods are limited in sensitivity and mainly focus on frequencies around 2 % to 5 %; most fail to consider differential sequencing artifacts. We aimed to push down the frequency detection limit close to the position specific sequencing error rates by modeling the observed erroneous read counts with respect to genomic sequence contexts. 4 distributions suitable for count data modeling (using generalized linear models) were extensively characterized in terms of their goodness-of-fit as well as the performances on real sequencing data benchmarks, which were specifically designed for testing detection of low-frequency variants; two sequencing technologies with significantly different chemistry mechanisms were used to explore systematic errors. We found the zero-inflated negative binomial distribution generalized linear mode is superior to the other models tested, and the advantage is most evident at 0.5 % to 1 % range. This method is also generalizable to different sequencing technologies. Under standard sequencing protocols and depth given in the testing benchmarks, 95.3 % recall and 79.9 % precision for Ion Proton data, 95.6 % recall and 97.0 % precision for Illumina MiSeq data were achieved for SNVs with frequency > = 1 %, while the detection limit is around 0.5 %. Our method enables sensitive detection of low-frequency single nucleotide variants across different sequencing platforms and will facilitate research and clinical applications such as pooled sequencing, cancer early detection, prognostic assessment, metastatic monitoring, and relapses or acquired resistance identification.
- 1 January 2015
- Published by American Psychological Association (APA)
Subjective Perceptions Assessment
- 1 January 2015
- Published by American Psychological Association (APA)
Subjective Perceptions Assessment
- Open Access
- 8 April 2010
- Published by Springer Nature in BMC Microbiology
- Vol. 10 (1) , 103
Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages
Background: Pneumocystispneumonia is a common opportunistic disease in AIDS patients. The alveolar macrophage is an important effector cell in the clearance ofPneumocystisorganisms by phagocytosis. However, both the number and phagocytic activity of alveolar macrophages are decreased inPneumocystisinfected hosts. To understand howPneumocystisinactivates alveolar macrophages, Affymetrix GeneChip®RG-U34A DNA microarrays were used to study the difference in global gene expression in alveolar macrophages from uninfected andPneumocystis carinii-infected Sprague-Dawley rats.Results: Analyses of genes that were affected byPneumocystisinfection showed that many functions in the cells were affected. Antigen presentation, cell-mediated immune response, humoral immune response, and inflammatory response were most severely affected, followed by cellular movement, immune cell trafficking, immunological disease, cell-to-cell signaling and interaction, cell death, organ injury and abnormality, cell signaling, infectious disease, small molecular biochemistry, antimicrobial response, and free radical scavenging. Since rats must be immunosuppressed in order to developPneumocystisinfection, alveolar macrophages from four rats of the same sex and age that were treated with dexamethasone for the entire eight weeks of the study period were also examined. With a filter of false-discovery rate less than 0.1 and fold change greater than 1.5, 200 genes were found to be up-regulated, and 144 genes were down-regulated by dexamethasone treatment. DuringPneumocystispneumonia, 115 genes were found to be up- and 137 were down-regulated with the same filtering criteria. The top ten genes up-regulated byPneumocystisinfection were Cxcl10, Spp1, S100A9, Rsad2, S100A8, Nos2, RT1-Bb, Lcn2, RT1-Db1, and Srgn with fold changes ranging between 12.33 and 5.34; and the top ten down-regulated ones were Lgals1, Psat1, Tbc1d23, Gsta1, Car5b, Xrcc5, Pdlim1, Alcam, Cidea, and Pkib with fold changes ranging between -4.24 and -2.25.Conclusions: In order to survive in the host,Pneumocystisorganisms change the expression profile of alveolar macrophages. Results of this study revealed thatPneumocystisinfection affects many cellular functions leading to reduced number and activity of alveolar macrophages duringPneumocystispneumonia.
- 8 April 2010
- Published by Springer Nature in BMC Microbiology
- Vol. 10 (1) , 103
Open AccessMicroarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages
Background: Pneumocystispneumonia is a common opportunistic disease in AIDS patients. The alveolar macrophage is an important effector cell in the clearance ofPneumocystisorganisms by phagocytosis. However, both the number and phagocytic activity of alveolar macrophages are decreased inPneumocystisinfected hosts. To understand howPneumocystisinactivates alveolar macrophages, Affymetrix GeneChip®RG-U34A DNA microarrays were used to study the difference in global gene expression in alveolar macrophages from uninfected andPneumocystis carinii-infected Sprague-Dawley rats.Results: Analyses of genes that were affected byPneumocystisinfection showed that many functions in the cells were affected. Antigen presentation, cell-mediated immune response, humoral immune response, and inflammatory response were most severely affected, followed by cellular movement, immune cell trafficking, immunological disease, cell-to-cell signaling and interaction, cell death, organ injury and abnormality, cell signaling, infectious disease, small molecular biochemistry, antimicrobial response, and free radical scavenging. Since rats must be immunosuppressed in order to developPneumocystisinfection, alveolar macrophages from four rats of the same sex and age that were treated with dexamethasone for the entire eight weeks of the study period were also examined. With a filter of false-discovery rate less than 0.1 and fold change greater than 1.5, 200 genes were found to be up-regulated, and 144 genes were down-regulated by dexamethasone treatment. DuringPneumocystispneumonia, 115 genes were found to be up- and 137 were down-regulated with the same filtering criteria. The top ten genes up-regulated byPneumocystisinfection were Cxcl10, Spp1, S100A9, Rsad2, S100A8, Nos2, RT1-Bb, Lcn2, RT1-Db1, and Srgn with fold changes ranging between 12.33 and 5.34; and the top ten down-regulated ones were Lgals1, Psat1, Tbc1d23, Gsta1, Car5b, Xrcc5, Pdlim1, Alcam, Cidea, and Pkib with fold changes ranging between -4.24 and -2.25.Conclusions: In order to survive in the host,Pneumocystisorganisms change the expression profile of alveolar macrophages. Results of this study revealed thatPneumocystisinfection affects many cellular functions leading to reduced number and activity of alveolar macrophages duringPneumocystispneumonia.
- 18 February 2010
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 153B (2) , 418-427
GABRR1andGABRR2, encoding the GABA‐A receptor subunits ρ1 and ρ2, are associated with alcohol dependence
The genes encoding several GABA‐A receptor subunits, includingGABRA2, have been associated with alcoholism, suggesting that variations in gaba signaling contribute to risk. Therefore, as part of a comprehensive evaluation of the GABA receptor genes, we evaluated the potential association ofGABRR1andGABRR2, which encode the ρ1 and ρ2 subunits of the pentameric GABA‐A/GABA‐C receptors.GABRR1andGABRR2lie in a head to tail orientation spanning 137 kb on chromosome 6q14‐16. We genotyped 73 single nucleotide polymorphisms (SNPs), covering both genes and extending 31 kb upstream ofGABRR2and 95 kb downstream ofGABRR1, in a sample of 1923 European Americans from 219 multiplex alcohol‐dependent families. Family‐based association analyses demonstrated that SNPs in bothGABRR1andGABRR2were significantly associated with alcohol dependence. Among the associated SNPs was rs282129, a coding SNP (Met430Thr) inGABRR2. Secondary analysis using a median split for age of onset suggests that the association is strongest when the analysis is focused upon those with earlier onset of alcohol dependence. Haplotypes in each gene were significantly overtransmitted to family members who did not meet criteria for alcohol dependence (P < 0.04), and a haplotype inGABRR2was significantly overtransmitted to family members who met a broader definition of alcoholism (P = 0.002) as well as DSM‐IV dependence (P = 0.04).
- 18 February 2010
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 153B (2) , 418-427
GABRR1andGABRR2, encoding the GABA‐A receptor subunits ρ1 and ρ2, are associated with alcohol dependence
The genes encoding several GABA‐A receptor subunits, includingGABRA2, have been associated with alcoholism, suggesting that variations in gaba signaling contribute to risk. Therefore, as part of a comprehensive evaluation of the GABA receptor genes, we evaluated the potential association ofGABRR1andGABRR2, which encode the ρ1 and ρ2 subunits of the pentameric GABA‐A/GABA‐C receptors.GABRR1andGABRR2lie in a head to tail orientation spanning 137 kb on chromosome 6q14‐16. We genotyped 73 single nucleotide polymorphisms (SNPs), covering both genes and extending 31 kb upstream ofGABRR2and 95 kb downstream ofGABRR1, in a sample of 1923 European Americans from 219 multiplex alcohol‐dependent families. Family‐based association analyses demonstrated that SNPs in bothGABRR1andGABRR2were significantly associated with alcohol dependence. Among the associated SNPs was rs282129, a coding SNP (Met430Thr) inGABRR2. Secondary analysis using a median split for age of onset suggests that the association is strongest when the analysis is focused upon those with earlier onset of alcohol dependence. Haplotypes in each gene were significantly overtransmitted to family members who did not meet criteria for alcohol dependence (P < 0.04), and a haplotype inGABRR2was significantly overtransmitted to family members who met a broader definition of alcoholism (P = 0.002) as well as DSM‐IV dependence (P = 0.04).
- 2 October 2007
- Published by Wiley in Addiction Biology
- Vol. 13 (1) , 80-87
HUMAN GENETIC STUDY: Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence
Recent studies in animal models have shown that the nociceptin system, comprising nociceptin (or OFQ/N, encoded byPNOC) and the nociceptin receptor (an opioid receptor‐like protein encoded byOPRL1), may be involved in alcohol and other drug reward pathways. To determine whether the nociceptin system is associated with alcohol or illicit drug dependence in humans, we analyzed 10 single nucleotide polymorphisms (SNPs) inOPRL1and 15 SNPs inPNOCin a sample of 1923 European Americans from 219 multiplex alcohol dependent families ascertained by the Collaborative Study on the Genetics of Alcoholism. The SNPs spanned both genes and several kb of their flanking sequences, and were in high linkage disequilibrium. Neither gene was associated with alcohol or illicit drug dependence, although two SNPs inPNOCshowed marginal association with alcoholism and one with illicit drug dependence (P = 0.04–0.05). Secondary analyses suggested that two adjacent SNPs in intron 1 ofOPRL1were marginally associated with opioid dependence (P = 0.05); none of the SNPs inPNOCwere associated with opioid dependence.
- 2 October 2007
- Published by Wiley in Addiction Biology
- Vol. 13 (1) , 80-87
HUMAN GENETIC STUDY: Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence
Recent studies in animal models have shown that the nociceptin system, comprising nociceptin (or OFQ/N, encoded byPNOC) and the nociceptin receptor (an opioid receptor‐like protein encoded byOPRL1), may be involved in alcohol and other drug reward pathways. To determine whether the nociceptin system is associated with alcohol or illicit drug dependence in humans, we analyzed 10 single nucleotide polymorphisms (SNPs) inOPRL1and 15 SNPs inPNOCin a sample of 1923 European Americans from 219 multiplex alcohol dependent families ascertained by the Collaborative Study on the Genetics of Alcoholism. The SNPs spanned both genes and several kb of their flanking sequences, and were in high linkage disequilibrium. Neither gene was associated with alcohol or illicit drug dependence, although two SNPs inPNOCshowed marginal association with alcoholism and one with illicit drug dependence (P = 0.04–0.05). Secondary analyses suggested that two adjacent SNPs in intron 1 ofOPRL1were marginally associated with opioid dependence (P = 0.05); none of the SNPs inPNOCwere associated with opioid dependence.
- 14 May 2007
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 144B (7) , 877-884
The opioid system in alcohol and drug dependence: Family‐based association study
Opioid receptors and their endogenous peptide ligands play important roles in neurotransmission and neuromodulation in response to addictive drugs such as heroin, cocaine, and alcohol. In an earlier study, we reported that variation in the genes encoding the κ‐opioid receptor (OPRK1)and its peptide ligand (PDYN)were associated with the risk for alcoholism. We continued our investigation of the role of the opioid system in alcohol dependence by analyzing the genes encoding the µ‐ and δ‐opioid receptors and their peptide ligands. We analyzed 18OPRM1SNPs, 18OPRD1SNPs, 7PENKSNPs, and 7POMCSNPs in a sample of 1923 European Americans from 219 multiplex alcohol dependent families. Employing a family‐based test of association, we found no evidence that these four genes were significantly associated with alcohol dependence. We also did not find association between these genes and illicit drug dependence. Secondary analyses employing the narrower phenotype of opioid dependence (83 affected individuals) demonstrated association with SNPs inPENKandPOMC, but not inOPRM1orOPRD1. Haplotype analyses provided further support for the association ofPENKandPOMCwith opioid dependence. Therefore, our data provide no support for the idea that variations inOPRM1,OPRD1,PENKandPOMCare associated with alcohol dependence or general illicit drug dependence, but variations inPENKandPOMCappear to be associated with the narrower phenotype of opioid dependence in these families.
- 14 May 2007
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 144B (7) , 877-884
The opioid system in alcohol and drug dependence: Family‐based association study
Opioid receptors and their endogenous peptide ligands play important roles in neurotransmission and neuromodulation in response to addictive drugs such as heroin, cocaine, and alcohol. In an earlier study, we reported that variation in the genes encoding the κ‐opioid receptor (OPRK1)and its peptide ligand (PDYN)were associated with the risk for alcoholism. We continued our investigation of the role of the opioid system in alcohol dependence by analyzing the genes encoding the µ‐ and δ‐opioid receptors and their peptide ligands. We analyzed 18OPRM1SNPs, 18OPRD1SNPs, 7PENKSNPs, and 7POMCSNPs in a sample of 1923 European Americans from 219 multiplex alcohol dependent families. Employing a family‐based test of association, we found no evidence that these four genes were significantly associated with alcohol dependence. We also did not find association between these genes and illicit drug dependence. Secondary analyses employing the narrower phenotype of opioid dependence (83 affected individuals) demonstrated association with SNPs inPENKandPOMC, but not inOPRM1orOPRD1. Haplotype analyses provided further support for the association ofPENKandPOMCwith opioid dependence. Therefore, our data provide no support for the idea that variations inOPRM1,OPRD1,PENKandPOMCare associated with alcohol dependence or general illicit drug dependence, but variations inPENKandPOMCappear to be associated with the narrower phenotype of opioid dependence in these families.
- 22 August 2006
- Published by Springer Nature in Molecular Psychiatry
- Vol. 11 (11) , 1016-1024
Association of the κ-opioid system with alcohol dependence
Opioid receptors and their endogenous peptide ligands play important roles in the reward and reinforcement of drugs such as heroin, cocaine, and alcohol. The binding of dynorphins to the κ-opioid receptor has been shown to produce aversive states, which may prevent the development of reinforcement. We genotyped SNPs throughout OPRK1, encoding the κ-opioid receptor, and PDYN, which encodes its ligand prodynorphin, in a group of 1860 European American individuals from 219 multiplex alcohol dependent families. Family-based analyses demonstrated associations between alcohol dependence and multiple SNPs in the promoter and 3′ end of PDYN, and in intron 2 of OPRK1. Haplotype analyses further supported the association of PDYN. Thus, variations in the genes encoding both the κ-opioid receptor and its ligand, OPRK1 and PDYN, are associated with the risk for alcohol dependence; this makes biological sense as variations in either should affect signaling through the κ-opioid system.
- 22 August 2006
- Published by Springer Nature in Molecular Psychiatry
- Vol. 11 (11) , 1016-1024
Association of the κ-opioid system with alcohol dependence
Opioid receptors and their endogenous peptide ligands play important roles in the reward and reinforcement of drugs such as heroin, cocaine, and alcohol. The binding of dynorphins to the κ-opioid receptor has been shown to produce aversive states, which may prevent the development of reinforcement. We genotyped SNPs throughout OPRK1, encoding the κ-opioid receptor, and PDYN, which encodes its ligand prodynorphin, in a group of 1860 European American individuals from 219 multiplex alcohol dependent families. Family-based analyses demonstrated associations between alcohol dependence and multiple SNPs in the promoter and 3′ end of PDYN, and in intron 2 of OPRK1. Haplotype analyses further supported the association of PDYN. Thus, variations in the genes encoding both the κ-opioid receptor and its ligand, OPRK1 and PDYN, are associated with the risk for alcohol dependence; this makes biological sense as variations in either should affect signaling through the κ-opioid system.
- Open Access
- 1 June 2003
- Published by Elsevier in SLAS Discovery
- Vol. 8 (3) , 273-282
Use of SAM2® Biotin Capture Membrane in Microarrayed Compound Screening (μARCS) Format for Nucleic Acid Polymerization Assays
- 1 June 2003
- Published by Elsevier in SLAS Discovery
- Vol. 8 (3) , 273-282
Open AccessUse of SAM2® Biotin Capture Membrane in Microarrayed Compound Screening (μARCS) Format for Nucleic Acid Polymerization Assays